{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:21:14Z","timestamp":1790968874392,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-026-07832-5","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T08:45:44Z","timestamp":1771404344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of mortality and causes of death between treatment-engaged individuals with severe alcohol or opioid use disorder: a prospective 19-year clinical cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Ivar","family":"Skeie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Berit","family":"Bech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne Jan","family":"Hjems\u00e6ter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Signe","family":"Landheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bent","family":"Monsbakken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magne","family":"Thoresen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge","family":"Waal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"7832_CR1","unstructured":"World Health Organization. Global status report on alcohol and health 2018 [Internet]. Geneva: WHO; 2018 https:\/\/iris.who.int\/bitstream\/handle\/10665\/274603\/9789241565639-eng.pdf?sequence=1 [cited 2025 Sep 8]"},{"key":"7832_CR2","unstructured":"European Union Drugs Agency. Drug-related deaths (DRD) standard protocol, version 3.2. Technical report. Lisbon: EUDA; 2009. Contract No.: December 18"},{"issue":"12","key":"7832_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S2215-0366(18)30337-7","volume":"5","author":"GB D","year":"2018","unstructured":"GBD. Alcohol and drug use Collaborators. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016. A systematic analysis for the global burden of disease study 2016. The Lancet Psychiatry. 2018;5(12):987\u20131012","journal-title":"The Lancet Psychiatry"},{"key":"7832_CR4","doi-asserted-by":"crossref","unstructured":"GBD 2016 Alcohol and Drug Use Collaborators. Correction to Lancet Psychiatry 2018; 5: 987-1012. The Lancet Psychiatry. 2019;6(1):e2.","DOI":"10.1016\/S2215-0366(18)30488-7"},{"key":"7832_CR5","unstructured":"World Health Organization. Global status report on alcohol and health and treatment of substance use disorders. Geneva. 2024"},{"issue":"3","key":"7832_CR6","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/ije\/dyu018","volume":"43","author":"M Roerecke","year":"2014","unstructured":"Roerecke M, Rehm J. Cause-specific mortality risk in alcohol use disorder treatment patients: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(3):906\u201319","journal-title":"Int J Epidemiol"},{"issue":"1","key":"7832_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1046\/j.1360-0443.2002.00079.x","volume":"97","author":"M Gossop","year":"2002","unstructured":"Gossop M, Stewart D, Treacy S, Marsden J. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction. 2002;97(1):39\u201347","journal-title":"Addiction"},{"issue":"3","key":"7832_CR8","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/acer.13594","volume":"42","author":"K Witkiewitz","year":"2018","unstructured":"Witkiewitz K, Vowles KE. Alcohol and opioid use, co-use, and chronic pain in the context of the opioid epidemic: a critical review. Alcohol Clin Exp Res. 2018;42(3):478\u201388","journal-title":"Alcohol Clin Exp Res"},{"key":"7832_CR9","unstructured":"European Union Drugs Agency. Polydrug use: health and social responses [Internet].; 2021 [updated 2021 Oct 22; cited 2025 Sep 8]. Available from: Lisbon: EUDA https:\/\/www.euda.europa.eu\/publications\/mini-guides\/polydrug-use-health-and-social-responses_en"},{"issue":"10","key":"7832_CR10","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.ebiom.2015.08.040","volume":"2","author":"P Laram\u00e9e","year":"2015","unstructured":"Laram\u00e9e P, Leonard S, Buchanan-Hughes A, Warnakula S, Daeppen JB, Rehm J. Risk of all-cause mortality in alcohol-dependent individuals: a systematic literature review and meta-analysis. EBioMedicine. 2015;2(10):1394\u2013404","journal-title":"EBioMedicine"},{"key":"7832_CR11","unstructured":"United Nations Office on Drugs and Crime. World Drug Report 2024. 2024"},{"issue":"1","key":"7832_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","volume":"106","author":"L Degenhardt","year":"2011","unstructured":"Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2011;106(1):32\u201351","journal-title":"Addiction"},{"issue":"5","key":"7832_CR13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1001\/jamapsychiatry.2019.4170","volume":"77","author":"S Larney","year":"2020","unstructured":"Larney S, Tran LT, Leung J, Santo T Jr, Santomauro D, Hickman M, et al. All-cause and cause-specific mortality among people using extramedical opioids: a systematic review and meta-analysis. JAMA Psychiatry. 2020;77(5):493\u2013502","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"7832_CR14","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1038\/s41380-018-0094-5","volume":"24","author":"J Ma","year":"2019","unstructured":"Ma J, Bao YP, Wang RJ, Su MF, Liu MX, Li JQ, et al. Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Mol Psychiatry. 2019;24(12):1868\u201383","journal-title":"Mol Psychiatry"},{"key":"7832_CR15","doi-asserted-by":"publisher","first-page":"j 1550","DOI":"10.1136\/bmj.j1550","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357: j 1550","journal-title":"BMJ"},{"issue":"4","key":"7832_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/acps.13088","volume":"140","author":"A Bahji","year":"2019","unstructured":"Bahji A, Cheng B, Gray S, Stuart H. Reduction in mortality risk with opioid agonist therapy: a systematic review and meta-analysis. Acta Psychiatr Scand. 2019;140(4):313\u201339","journal-title":"Acta Psychiatr Scand"},{"issue":"9","key":"7832_CR17","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","volume":"78","author":"T Santo Jr","year":"2021","unstructured":"Santo T Jr, Clark B, Hickman M, Grebely J, Campbell G, Sordo L, et al. Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis. JAMA Psychiatry. 2021;78(9):979\u201393","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"7832_CR18","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1001\/jamapsychiatry.2023.2342","volume":"80","author":"T Santo Jr","year":"2023","unstructured":"Santo T Jr. Errors in data reported in meta-analysis on opioid agonist treatment and mortality. JAMA Psychiatry. 2023;80(9):971\u201372","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"7832_CR19","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1111\/add.16297","volume":"118","author":"JG Bramness","year":"2023","unstructured":"Bramness JG, Heiberg IH, H\u00f8ye A, Rossow I. Mortality and alcohol-related morbidity in patients with delirium tremens, alcohol withdrawal state or alcohol dependence in Norway: a register-based prospective cohort study. Addiction. 2023;118(12):2352\u201359","journal-title":"Addiction"},{"issue":"6","key":"7832_CR20","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/dar.13669","volume":"42","author":"A Havard","year":"2023","unstructured":"Havard A, Jones N, Bharat C, Gisev N, Pearson SA, Shakeshaft A, et al. Mortality during and after specialist alcohol and other drug treatment: variation in rates according to principal drug of concern and treatment modality. Drug Alcohol Rev. 2023;42(6):1461\u201371","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"7832_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000067732","volume":"9","author":"AS Landheim","year":"2003","unstructured":"Landheim AS, Bakken K, Vaglum P. Gender differences in the prevalence of symptom disorders and personality disorders among poly-substance abusers and pure alcoholics. Substance abusers treated in two counties in Norway. Eur Addict Res. 2003;9(1):8\u201317","journal-title":"Eur Addict Res"},{"issue":"1","key":"7832_CR22","doi-asserted-by":"publisher","first-page":"e000130","DOI":"10.1136\/bmjopen-2011-000130","volume":"1","author":"I Skeie","year":"2011","unstructured":"Skeie I, Brekke M, Gossop M, Lindbaek M, Reinertsen E, Thoresen M, et al. Changes in somatic disease incidents during opioid maintenance treatment: results from a Norwegian cohort study. BMJ Open. 2011;1(1):e000130","journal-title":"BMJ Open"},{"issue":"5","key":"7832_CR23","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1159\/000525694","volume":"28","author":"I Skeie","year":"2022","unstructured":"Skeie I, Clausen T, Hjems\u00e6ter AJ, Landheim AS, Monsbakken B, Thoresen M, et al. Mortality, causes of death, and predictors of death among patients on and off opioid agonist treatment: results from a 19-year cohort study. Eur Addict Res. 2022;28(5):358\u201367","journal-title":"Eur Addict Res"},{"issue":"1","key":"7832_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12888-019-2077-8","volume":"19","author":"AJ Hjems\u00e6ter","year":"2019","unstructured":"Hjems\u00e6ter AJ, Bramness JG, Drake R, Skeie I, Monsbakken B, Benth J, et al. Mortality, cause of death and risk factors in patients with alcohol use disorder alone or poly-substance use disorders: a 19-year prospective cohort study. BMC Psychiatry. 2019;19(1):101","journal-title":"BMC Psychiatry"},{"key":"#cr-split#-7832_CR25.1","unstructured":"Norwegian Institute of Public Health. Norhealth statistics bank 2021 [updated 2021 June 15"},{"key":"#cr-split#-7832_CR25.2","unstructured":"cited 2024 December 18]. Available from: https:\/\/www.fhi.no\/op\/dodsarsaksregisteret\/"},{"key":"#cr-split#-7832_CR26.1","unstructured":"Statistics Norway. Deaths, by sex and one-year age group 1986-2020 [Internet]. 2021 [updated 2021 Mar 11"},{"key":"#cr-split#-7832_CR26.2","unstructured":"cited 2024 Dec 18]. Available from https:\/\/www.ssb.no\/en\/statbank\/table\/10325"},{"issue":"1","key":"7832_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/bs.3830190102","volume":"19","author":"LR Derogatis","year":"1974","unstructured":"Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The hopkins symptom checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974;19(1):1\u201315","journal-title":"Behav Sci"},{"key":"7832_CR28","unstructured":"American Society of Addiction Medicine. The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update [Internet]. ASAM; 2020 [cited 2024 Dec 18]. Available from: https:\/\/www.asam.org\/quality-care\/clinical-guidelines\/national-practice-guideline"},{"key":"7832_CR29","unstructured":"Centre for Addiction and Mental Health. Opioid agonist therapy: A synthesis of Canadian guidelines for treating opioid use disorder [Internet]. 2021 [cited 2024 Dec 18].\u00a0Available from: https:\/\/www.camh.ca\/-\/media\/professionals-files\/canadian-opioid-use-disorder-guideline2021-pdf.pdf"},{"key":"#cr-split#-7832_CR30.1","unstructured":"Norwegian Health Directorate. National guideline for the treatment of opioid use disorder Oslo2022 [updated 2024 May 16"},{"key":"#cr-split#-7832_CR30.2","unstructured":"cited 2024 December 18]. Available from: https:\/\/www.helsedirektoratet.no\/retningslinjer\/behandling-ved-opioidavhengighet"},{"key":"7832_CR31","volume-title":"Twenty-five years with opioid agonist treatment","author":"L Nesse","year":"2024","unstructured":"Nesse L, Lobmaier P, Skeie I, Lillevold PH, Clausen T. Twenty-five years with opioid agonist treatment. Oslo: Norwegian Centre for Addiction Research; 2024"},{"key":"7832_CR32","unstructured":"European Union Drugs Agency. Opioid agonist treatment: the current situation in Europe (European Drug Report 2024) [Internet]. Lisbon: EUDA; 2024 [updated 2024 Jun 11; cited 2024 Dec 18].: https:\/\/www.euda.europa.eu\/publications\/european-drug-report\/2024\/opioid-agonist-treatment_en"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-07832-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-07832-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-07832-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T12:35:03Z","timestamp":1772714103000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-07832-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7832"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-07832-5","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Regional Committee for Medical and Health Research Ethics, Health Region South-East (ID 2014\/1936 C). All participants alive gave their written consent before taking part in the original study and could decline participation in the follow-up study. Exemption from professional secrecy duty of confidentiality for those dead was given by the Norwegian Directorate of Health (original studies, see Fig.\n                      \n                      ) and the Ethics Committee (above, follow-up study).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"229"}}